BioNTech's Q2 revenues double on higher COVID vaccine sales

Go back to BioNTech's Q2 revenues double on higher COVID vaccine sales
(NASDAQ: BNTX) Delayed: 102.08 --0 (-0%)
Previous Close $102.08    52 Week High
Open $102.08    52 Week Low
Day High $102.08    P/E N/A 
Day Low $102.08    EPS
Volume 4,409